The online version of this article (https://doi.org/10.1186/s12877-017-0703-1) contains supplementary material, which is available to authorized users.
Older people with multi-morbidity are increasingly challenging for today’s healthcare, and novel, cost-effective healthcare solutions are needed. The aim of this study was to assess the cost-effectiveness of comprehensive geriatric assessment (CGA) at an ambulatory geriatric unit for people ≥75 years with multi-morbidity.
The primary outcome was the incremental cost-effectiveness ratio (ICER) comparing costs and quality-adjusted life years (QALYs) of a CGA strategy with usual care in a Swedish setting. Outcomes were estimated over a lifelong time horizon using decision-analytic modelling based on data from the randomized AGe-FIT trial. The analysis employed a public health care sector perspective. Costs and QALYs were discounted by 3% per annum and are reported in 2016 euros.
Compared with usual care CGA was associated with a per patient mean incremental cost of approximately 25,000 EUR and a gain of 0.54 QALYs resulting in an ICER of 46,000 EUR. The incremental costs were primarily caused by intervention costs and costs associated with increased survival, whereas the gain in QALYs was primarily a consequence of the fact that patients in the CGA group lived longer.
CGA in an ambulatory setting for older people with multi-morbidity results in a cost per QALY of 46,000 EUR compared with usual care, a figure generally considered reasonable in a Swedish healthcare context. A rather simple reorganisation of care for older people with multi-morbidity may therefore cost effectively contribute to meet the needs of this complex patient population.
The trial was retrospectively registered in clinicaltrial.gov, NCT01446757. September, 2011.
Additional file 1: Mortality. Annual mortality probabilities applied in the model (DOCX 10284 kb)12877_2017_703_MOESM1_ESM.docx
Additional file 2: Uncertainty and sensitivity analysis. Detailed parameter estimates used in the model and results of sensitivity analysis (DOCX 23 kb)12877_2017_703_MOESM2_ESM.docx
SBU. Comprehensive geriatric assessment and care for frail elderly. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2014. SBU report no 221 (in Swedish).
Ellis G, Whitehead MA, O'Neill D, Langhorne P, Robinson D. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2011;(7):CD006211.
Tanajewski L, Franklin M, Gkountouras G, Berdunov V, Edmans J, Conroy S, et al. Cost-effectiveness of a specialist geriatric medical intervention for frail older people discharged from acute medical units: economic evaluation in a two-Centre randomised controlled trial (AMIGOS). PLoS One. 2015;10:e0121340. CrossRefPubMedPubMedCentral
Claxton K, Sculpher M, Drummond M. A Rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet. 2002;360:711-5.
Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation: Oxford University Press; 2006.
Mazya AL, Eckerblad J, Jaarsma T, Hellström I, Krevers B, Milberg A, et al. The ambulatory geriatric assessment - a frailty intervention trial (AGe-FIT) - a randomized controlled trial aimed to prevent hospital readmissions and functional deterioration in high risk older adults: a study protocol. Eur Geriatr Med. 2013;4:242–7. CrossRef
Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
Sonnenberg F, Beck J. Markov models in medical decision making: a practical guide. Med Decis Mak. 1993;13:322–38. CrossRef
Burström K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Res. 2001;10:621–35.
www.scb.se. Accessed 29 Mar 2017.
Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005;14:339–47.
IBM Corp. Released 2013. IBM SPSS for windows, version 22.0. Armonk: IBM Corp.
- Cost-effectiveness of comprehensive geriatric assessment at an ambulatory geriatric unit based on the AGe-FIT trial
Anne W. Ekdahl
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II